Mathew M. Mulhern;Andrew J. Souers;Philip R. Kym;Andrew S. Judd;Rajesh R. lyengar
发明人:
Andrew S. Judd,Mathew M. Mulhern,Rajesh R. lyengar,Philip R. Kym,Andrew J. Souers
申请号:
US13549651
公开号:
US20120277223A1
申请日:
2012.07.16
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention relates to compounds of formula (I):wherein Q, G1, G2, and G3, are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.